ID   STRAA_HUMAN             Reviewed;         431 AA.
AC   Q7RTN6; Q7Z4K9; Q8NC31; Q8NCF1; Q9H272;
DT   28-NOV-2006, integrated into UniProtKB/Swiss-Prot.
DT   15-DEC-2003, sequence version 1.
DT   05-OCT-2010, entry version 65.
DE   RecName: Full=STE20-related kinase adapter protein alpha;
DE            Short=STRAD alpha;
DE   AltName: Full=STE20-related adapter protein;
DE   AltName: Full=Serologically defined breast cancer antigen NY-BR-96;
GN   Name=STRADA; Synonyms=LYK5, STRAD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Mammary tumor;
RX   MEDLINE=22633220; PubMed=12747765;
RA   Scanlan M.J., Gout I., Gordon C.M., Williamson B., Stockert E.,
RA   Gure A.O., Jaeger D., Chen Y.-T., Mackay A., O'Hare M.J., Old L.J.;
RT   "Humoral immunity to human breast cancer: antigen definition and
RT   quantitative analysis of mRNA expression.";
RL   Cancer Immun. 1:4-4(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Shan Y.X., Huang C.Q., Yu L.;
RT   "Cloning, characterization and localization of lyk5 gene.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   IDENTIFICATION (ISOFORM 1), FUNCTION, SUBCELLULAR LOCATION,
RP   INTERACTION WITH STK11, MUTAGENESIS OF THR-329 AND THR-419, AND
RP   PHOSPHORYLATION AT THR-329 AND THR-419.
RX   MEDLINE=22688956; PubMed=12805220; DOI=10.1093/emboj/cdg292;
RA   Baas A.F., Boudeau J., Sapkota G.P., Smit L., Medema R., Morrice N.A.,
RA   Alessi D.R., Clevers H.C.;
RT   "Activation of the tumour suppressor kinase LKB1 by the STE20-like
RT   pseudokinase STRAD.";
RL   EMBO J. 22:3062-3072(2003).
RN   [5]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH STK11 AND CAB39.
RX   PubMed=14517248; DOI=10.1093/emboj/cdg490;
RA   Boudeau J., Baas A.F., Deak M., Morrice N.A., Kieloch A.,
RA   Schutkowski M., Prescott A.R., Clevers H.C., Alessi D.R.;
RT   "MO25alpha/beta interact with STRADalpha/beta enhancing their ability
RT   to bind, activate and localize LKB1 in the cytoplasm.";
RL   EMBO J. 22:5102-5114(2003).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) IN COMPLEX WITH CAB39.
RX   PubMed=14730349; DOI=10.1038/nsmb716;
RA   Milburn C.C., Boudeau J., Deak M., Alessi D.R., van Aalten D.M.;
RT   "Crystal structure of MO25 alpha in complex with the C-terminus of the
RT   pseudo kinase STE20-related adaptor.";
RL   Nat. Struct. Mol. Biol. 11:193-200(2004).
RN   [8]
RP   INVOLVEMENT IN PMSE.
RX   PubMed=17522105; DOI=10.1093/brain/awm100;
RA   Puffenberger E.G., Strauss K.A., Ramsey K.E., Craig D.W.,
RA   Stephan D.A., Robinson D.L., Hendrickson C.L., Gottlieb S.,
RA   Ramsay D.A., Siu V.M., Heuer G.G., Crino P.B., Morton D.H.;
RT   "Polyhydramnios, megalencephaly and symptomatic epilepsy caused by a
RT   homozygous 7-kilobase deletion in LYK5.";
RL   Brain 130:1929-1941(2007).
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] TRP-13; ILE-60 AND SER-64.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Pseudokinase which, in complex with CAB39, binds to and
CC       activates STK11. Relocates STK11 from the nucleus to the
CC       cytoplasm. Plays an essential role in STK11-mediated G1 cell cycle
CC       arrest.
CC   -!- INTERACTION:
CC       Q15831:STK11; NbExp=3; IntAct=EBI-1109114, EBI-306838;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q7RTN6-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7RTN6-2; Sequence=VSP_052219, VSP_052220, VSP_052221;
CC       Name=3;
CC         IsoId=Q7RTN6-3; Sequence=VSP_052219;
CC   -!- DOMAIN: The protein kinase domain is predicted to be catalytically
CC       inactive.
CC   -!- DISEASE: Deletions involving STRADA are the cause of
CC       polyhydramnios, megalencephaly, and symptomatic epilepsy syndrome
CC       (PMSE) [MIM:611087]. Affected children have large heads,
CC       infantile-onset intractable multifocal seizures and severe
CC       psychomotor retardation. Neuropathological studies reveal
CC       megalencephaly, ventriculomegaly, cytomegaly and extensive
CC       vacuolization and astrocytosis of white matter.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF308302; AAG48269.1; -; mRNA.
DR   EMBL; AY290821; AAP42280.1; -; mRNA.
DR   EMBL; AK074771; BAC11197.1; -; mRNA.
DR   EMBL; AK075005; BAC11349.1; -; mRNA.
DR   EMBL; BK001542; DAA01797.1; -; mRNA.
DR   IPI; IPI00300700; -.
DR   IPI; IPI00396083; -.
DR   IPI; IPI00456673; -.
DR   RefSeq; NP_001003786.1; -.
DR   RefSeq; NP_001003787.1; -.
DR   RefSeq; NP_001003788.1; -.
DR   RefSeq; NP_001159441.1; -.
DR   RefSeq; NP_001159442.1; -.
DR   RefSeq; NP_699166.2; -.
DR   UniGene; Hs.514402; -.
DR   PDB; 1UPK; X-ray; 1.85 A; B=420-431.
DR   PDB; 2WTK; X-ray; 2.65 A; B/E=59-431.
DR   PDB; 3GNI; X-ray; 2.35 A; B=59-431.
DR   PDBsum; 1UPK; -.
DR   PDBsum; 2WTK; -.
DR   PDBsum; 3GNI; -.
DR   ProteinModelPortal; Q7RTN6; -.
DR   SMR; Q7RTN6; 52-384.
DR   DIP; DIP-35775N; -.
DR   IntAct; Q7RTN6; 8.
DR   MINT; MINT-1338485; -.
DR   STRING; Q7RTN6; -.
DR   PhosphoSite; Q7RTN6; -.
DR   PRIDE; Q7RTN6; -.
DR   Ensembl; ENST00000336174; ENSP00000336655; ENSG00000125695.
DR   GeneID; 92335; -.
DR   KEGG; hsa:92335; -.
DR   UCSC; uc002jbm.1; human.
DR   UCSC; uc002jbp.1; human.
DR   CTD; 92335; -.
DR   GeneCards; GC17M061780; -.
DR   HGNC; HGNC:30172; STRADA.
DR   HPA; HPA031637; -.
DR   MIM; 608626; gene.
DR   MIM; 611087; phenotype.
DR   HOGENOM; HBG715330; -.
DR   HOVERGEN; HBG055069; -.
DR   InParanoid; Q7RTN6; -.
DR   OMA; NGTVPCL; -.
DR   OrthoDB; EOG93R66N; -.
DR   PhylomeDB; Q7RTN6; -.
DR   Reactome; REACT_11163; Activated AMPK stimulates fatty-acid oxidation in muscle.
DR   Reactome; REACT_498; Signaling by Insulin receptor.
DR   NextBio; 77700; -.
DR   ArrayExpress; Q7RTN6; -.
DR   Bgee; Q7RTN6; -.
DR   CleanEx; HS_STRADA; -.
DR   Genevestigator; Q7RTN6; -.
DR   GermOnline; ENSG00000125695; Homo sapiens.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005515; F:protein binding; IPI:IntAct.
DR   GO; GO:0004672; F:protein kinase activity; IEA:InterPro.
DR   GO; GO:0032147; P:activation of protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   GO; GO:0006611; P:protein export from nucleus; IDA:UniProtKB.
DR   GO; GO:0046320; P:regulation of fatty acid oxidation; EXP:Reactome.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   Pfam; PF00069; Pkinase; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Cell cycle;
KW   Chromosomal rearrangement; Complete proteome; Cytoplasm; Kinase;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Transferase.
FT   CHAIN         1    431       STE20-related kinase adapter protein
FT                                alpha.
FT                                /FTId=PRO_0000260035.
FT   DOMAIN       69    379       Protein kinase.
FT   MOD_RES      46     46       Phosphoserine.
FT   MOD_RES     329    329       Phosphothreonine; by STK11.
FT   MOD_RES     419    419       Phosphothreonine; by STK11.
FT   VAR_SEQ       5     41       Missing (in isoform 2 and isoform 3).
FT                                /FTId=VSP_052219.
FT   VAR_SEQ     368    417       PSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQS
FT                                QDHSGIFGL -> YPCWPGPGLRESRGCSGG (in
FT                                isoform 2).
FT                                /FTId=VSP_052220.
FT   VAR_SEQ     418    431       Missing (in isoform 2).
FT                                /FTId=VSP_052221.
FT   VARIANT      13     13       R -> W (in dbSNP:rs35808156).
FT                                /FTId=VAR_041377.
FT   VARIANT      60     60       S -> I (in dbSNP:rs56271007).
FT                                /FTId=VAR_041378.
FT   VARIANT      64     64       P -> S (in dbSNP:rs55695051).
FT                                /FTId=VAR_041379.
FT   MUTAGEN     329    329       T->A: Loss of STK11-mediated
FT                                phosphorylation.
FT   MUTAGEN     419    419       T->A: Loss of STK11-mediated
FT                                phosphorylation.
FT   CONFLICT    339    339       S -> W (in Ref. 1; AAG48269).
FT   CONFLICT    363    363       N -> H (in Ref. 3; BAC11349).
FT   CONFLICT    388    388       E -> K (in Ref. 1; AAG48269).
SQ   SEQUENCE   431 AA;  48369 MW;  9CC0A78D9CC6FC2C CRC64;
     MSFLVSKPER IRRWVSEKFI VEGLRDLELF GEQPPGDTRR KTNDASSESI ASFSKQEVMS
     SFLPEGGCYE LLTVIGKGFE DLMTVNLARY KPTGEYVTVR RINLEACSNE MVTFLQGELH
     VSKLFNHPNI VPYRATFIAD NELWVVTSFM AYGSAKDLIC THFMDGMNEL AIAYILQGVL
     KALDYIHHMG YVHRSVKASH ILISVDGKVY LSGLRSNLSM ISHGQRQRVV HDFPKYSVKV
     LPWLSPEVLQ QNLQGYDAKS DIYSVGITAC ELANGHVPFK DMPATQMLLE KLNGTVPCLL
     DTSTIPAEEL TMSPSRSVAN SGLSDSLTTS TPRPSNGDSP SHPYHRTFSP HFHHFVEQCL
     QRNPDARPSA STLLNHSFFK QIKRRASEAL PELLRPVTPI TNFEGSQSQD HSGIFGLVTN
     LEELEVDDWE F
//
